| Bioactivity | SARS-CoV-2 3CLpro-IN-20 (Compound 5g) is a covalent SARS-CoV-2 3CLpro inhibitor (IC50s: 0.43 μM, Ki: ?0.33?μM)[1]. |
| Target | 0.43 μM (SARS-CoV-2 3CLpro) |
| Name | SARS-CoV-2 3CLpro-IN-20 |
| CAS | 878985-00-3 |
| Formula | C19H12BrNO2 |
| Molar Mass | 366.21 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Bao HL, et al. Design and synthesis of isatin derivatives as effective SARS-CoV-2 3CL protease inhibitors. Chem Biol Drug Des. 2023 Aug 10. |
SARS-CoV-2 3CLpro-IN-20
CAS: 878985-00-3 F: C19H12BrNO2 W: 366.21
SARS-CoV-2 3CLpro-IN-20 (Compound 5g) is a covalent SARS-CoV-2 3CLpro inhibitor (IC50s: 0.43 μM, Ki: ?0.33?μM).
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.